Islet Amyloid Polypeptide Market - Type 2 Diabetes Pathophysiology and Therapeutic Target
Market Overview
The global islet amyloid polypeptide (IAPP/amylin) market is experiencing growth driven by increasing recognition of amylin pathway importance in type 2 diabetes pathophysiology, development of amylin mimetic therapeutics, and pharmaceutical innovation enabling effective IAPP-based treatments. The islet amyloid polypeptide market is projected to exceed USD 8.2 billion through...
